Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Stefan Zielen, Prof. Dr
Woman and Man Max 99 years
Stefan Zielen, Prof. Dr
Update Il y a 5 ans
Body Composition and Hormonal Status in Ataxia Telangiectasia
Ataxia telangiectasia (A-T) is a rare devastating human recessive disorder characterized by progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and cancer susceptibil...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Stefan Zielen, Prof. Dr
Update Il y a 5 ans
Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
Explorative comparison of montelukast with inhaled steroids (fluticasone) to estimate responder profiles, in terms of symptom scores, rescue medication, increase of FEV1, in correlation to...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Stefan Zielen, Prof. Dr
Update Il y a 5 ans
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
This study will evaluate the status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth failure, body weight and composition and neuroprotection in ch...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Stefan Zielen, Prof. Dr
Update Il y a 5 ans
Susceptibility to Infections in Ataxia Telangiectasia
Death in Ataxia telangiectasia (A-T) is usually due to cancer or chronic lung failure around 20 years of age. Despite low lymphocyte counts (CD3, CD4, CD8 and CD19), IgA and IgG subclass d...
Country
None
organs
None
Specialty
None
unknown
More information